RMD
RESMED INC
NYSE · Healthcare · Medical - Instruments & Supplies · US
$227.08
−2.52%Price chart
Oct 5Oct 8Oct 13Oct 16Oct 21Oct 26Oct 29Nov 3
Key dataNov 3, 2026
Open$227.01
From 52W high−17.71%
Volume2.14M
Market cap$31.94B
P/E (TTM)20.7x
P/S (TTM)5.6x
Div yield1.08%
Key dataNov 3, 2026
Open
$227.01
From 52W high
−17.71%
Volume
2.14M
Market cap
$31.94B
ValuationView details →
P/E (Fwd)
18.4x
EV/EBITDA
14.1x
P/E (TTM)
20.7x
RSI (14)
38.4
MomentumView details →
1D Return
−2.52%
YTD Return
−6.83%
SummaryUpdated Sep 1, 2026
ResMed Inc. (NYSE:RMD) is a medical device company founded in 1989 and headquartered in San Diego, California. The company went public in 1995 and has evolved from a sleep apnea device manufacturer into a comprehensive digital health platform serving patients with sleep-disordered breathing and other respiratory conditions. ResMed operates globally across approximately 140 countries, developing cloud-connected medical devices and software solutions that serve both patients in their homes and healthcare providers managing out-of-hospital care.
Similar companies
Latest newsMore news →
RESMED INC reported quarterly earnings of $2.91 per share, above the Zacks Investment Research, Inc. Consensus Estimate of $2.67 and up from $2.55 per share a year earlier.6d agoRESMED INC reported fiscal 2027 first-quarter revenue up 5.9% year over year to $1.41481 billion and operating income up 1.4% to $452.98 million, with diluted EPS of $2.92.6d agoRESMED INC increased its quarterly dividend by $0.06 to $0.66 per share.6d ago